FDAnews
www.fdanews.com/articles/132496-stryker-selling-controversial-bone-growth-line-for-60-million

Stryker Selling Controversial Bone Growth Line for $60 Million

December 7, 2010
Orthopedics company Stryker Corp. has agreed to sell a product line including the bone growth putty that has caused the company so much legal grief to Olympus Corp. for $60 million.
MedCity News